Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trial

Cook, G., Ashcroft, A.J., Senior, E. et al. (17 more authors) (2024) Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trial. The Lancet Haematology, 11 (11). e816-e829. ISSN 2352-3026

Abstract

Metadata

Item Type: Article
Authors/Creators:
  • Cook, G.
  • Ashcroft, A.J.
  • Senior, E.
  • Olivier, C.
  • Hockaday, A.
  • Richards, J.
  • Cavenagh, J.D.
  • Snowden, J.A. ORCID logo https://orcid.org/0000-0001-6819-3476
  • Drayson, M.T.
  • de Tute, R.
  • Roberts, L.
  • Owen, R.G.
  • Yong, K.
  • Garg, M.
  • Boyd, K.
  • Sati, H.
  • Gillson, S.
  • Cook, M.
  • Cairns, D.A.
  • Parrish, C.
Copyright, Publisher and Additional Information:

© 2024 The Authors. This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Keywords: United Kingdom Myeloma Research Alliance
Dates:
  • Published: November 2024
  • Published (online): 6 September 2024
  • Accepted: 31 July 2024
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 16 Sep 2024 10:15
Last Modified: 26 Feb 2025 15:17
Status: Published
Publisher: Elsevier BV
Refereed: Yes
Identification Number: 10.1016/s2352-3026(24)00249-7
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics